VOYA Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Sell
39,818
-705
-2% -$2.23K ﹤0.01% 2195
2025
Q4
$150K Buy
40,523
+2,527
+7% +$8.17K ﹤0.01% 2202
2025
Q3
$101K Sell
37,996
-18,584
-33% -$35.9K ﹤0.01% 2302
2025
Q2
$55.7K Buy
56,580
+3,814
+7% +$3.82K ﹤0.01% 2583
2025
Q1
$76K Sell
52,766
-5,971
-10% -$11K ﹤0.01% 2481
2024
Q4
$129K Sell
58,737
-4,405
-7% -$10.3K ﹤0.01% 2514
2024
Q3
$104K Buy
63,142
+113
+0.2% +$228 ﹤0.01% 2653
2024
Q2
$140K Buy
+63,029
New +$148K ﹤0.01% 2583
2023
Q2
Sell
-28,043
Closed -$44.6K 2946
2023
Q1
$44.6K Hold
28,043
﹤0.01% 2816
2022
Q4
$175K Buy
28,043
+1,514
+6% +$10.8K ﹤0.01% 2621
2022
Q3
$178K Buy
26,529
+2,142
+9% +$14.7K ﹤0.01% 2635
2022
Q2
$155K Sell
24,387
-23,048
-49% -$131K ﹤0.01% 2493
2022
Q1
$220K Buy
+47,435
New +$203K ﹤0.01% 2317
2021
Q4
Sell
-10,593
Closed -$128K 2789
2021
Q3
$128K Hold
10,593
﹤0.01% 2684
2021
Q2
$224K Sell
10,593
-1,187
-10% -$28.6K ﹤0.01% 2543
2021
Q1
$330K Buy
11,780
+624
+6% +$18.4K ﹤0.01% 2271
2020
Q4
$290K Buy
11,156
+2,247
+25% +$67.3K ﹤0.01% 2209
2020
Q3
$331K Hold
8,909
﹤0.01% 1889
2020
Q2
$457K Sell
8,909
-3,700
-29% -$155K ﹤0.01% 1729
2020
Q1
$398K Buy
12,609
+347
+3% +$18.3K ﹤0.01% 1761
2019
Q4
$731K Buy
12,262
+2,537
+26% +$114K ﹤0.01% 1649
2019
Q3
$357K Hold
9,725
﹤0.01% 1948
2019
Q2
$452K Buy
9,725
+274
+3% +$12.9K ﹤0.01% 1845
2019
Q1
$379K Hold
9,451
﹤0.01% 1932
2018
Q4
$435K Sell
9,451
-103,437
-92% -$4.98M ﹤0.01% 1812
2018
Q3
$5.01M Sell
112,888
-287,925
-72% -$13.2M 0.01% 819
2018
Q2
$15.7M Buy
400,813
+83,551
+26% +$4.22M 0.03% 493
2018
Q1
$22.9M Buy
317,262
+309,589
+4,035% +$22.7M 0.05% 385
2017
Q4
$505K Hold
7,673
﹤0.01% 1831
2017
Q3
$385K Buy
7,673
+525
+7% +$25.3K ﹤0.01% 2028
2017
Q2
$331K Buy
7,148
+806
+13% +$29.6K ﹤0.01% 2091
2017
Q1
$224K Buy
+6,342
New +$145K ﹤0.01% 2218
2016
Q4
Sell
-689,910
Closed -$9.55K 2529
2016
Q3
$9.55K Sell
689,910
-241,450
-26% -$2.74M 0.02% 604
2016
Q2
$9.2M Buy
931,360
+298,968
+47% +$4.95M 0.02% 592
2016
Q1
$10.7M Buy
632,392
+184,550
+41% +$2.97M 0.03% 521
2015
Q4
$9.97M Buy
447,842
+168,775
+60% +$4.26M 0.02% 555
2015
Q3
$6.58M Buy
279,067
+91,475
+49% +$5.74M 0.02% 692
2015
Q2
$15.3M Buy
187,592
+137,727
+276% +$13.5M 0.04% 434
2015
Q1
$4.62M Buy
+49,865
New +$3.22M 0.01% 826

Other funds holding ESPR